NCT06854978 R3THA Rehabilitation Feasibility and Usability Study
| NCT ID | NCT06854978 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kessler Foundation |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-03-27 |
| Primary Completion | 2026-03-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2024-03-27 with a primary completion date of 2026-03-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess how the Rehabilitation Technologies for Hand and Arm (R3THA) device can be used for rehabilitation of people with stroke. the study will evaluate the feasibility of R3THA as outpatient telerehabilitation administered by trained clinicians to individuals with stroke.
Eligibility Criteria
Inclusion Criteria: 1. must be between the ages of 20 and 80 2. must have enough movement in my arms and hands to actively interact with the video games as determined by study staff 3. must have internet access at home. 4. must be comfortable performing basic functions on a computer, such as browsing the internet. 5. must be able to sit without a loss of balance while performing activities with my arms and hands as determined by study staff. Exclusion Criteria: Severe muscle spasms or stiffness (spasticity) in the affected upper limb that limits movement, as determined by study staff. 2\) Thinking problems or have difficulty following instructions 3) Unable to interact with an entire computer screen due to spatial neglect 4) Difficulty understanding words spoken to me (Receptive aphasia) 5) Any other disabling nervous system condition (besides stroke) that has caused residual weakness, impaired range of motion, or spasticity 6) Severe arthritis that limits hand and arm movements 7) Not independent in functional activities/mobility prior to stroke
Contact & Investigator
Kiran Karunakaran, PhD
PRINCIPAL INVESTIGATOR
Kessler Foundation
Frequently Asked Questions
Who can join the NCT06854978 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06854978 currently recruiting?
Yes, NCT06854978 is actively recruiting participants. Contact the research team at kkarunakaran@kesslerfoundation.org for enrollment information.
Where is the NCT06854978 trial being conducted?
This trial is being conducted at West Orange, United States.
Who is sponsoring the NCT06854978 clinical trial?
NCT06854978 is sponsored by Kessler Foundation. The principal investigator is Kiran Karunakaran, PhD at Kessler Foundation. The trial plans to enroll 10 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.